Clinical Trial Update: A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging [Phase 3]

View source ↗

Summary

Phase 3 study of gadodiamide injection for myocardial perfusion MRI in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Gadodiamide (gadodiamide)

Snippet

Sponsor: Amersham Buchler, GmbH & Co KG | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED